Company news
Jacobio Pharmaceuticals Group Co., Ltd. news in 2021
Jacobio Pharmaceuticals Group Co., Ltd.'s news releases, calls and decks from 2021, newest first.
Jacobio Pharmaceuticals Group: Voluntary announcement jacobio announces the first patient dosed in clinical trial of kras G12C jab-21822 in china
August 3, 2021
Jacobio Pharmaceuticals Group: Voluntary announcement jacobio receives US FDA investigational new drug clearance for kras G12C inhibitor
May 2, 2021
Resignation of president of research and development and appointment of chief biologist
April 30, 2021
Jacobio Pharmaceuticals Group: Proposed granting of general mandates to issue shares and repurchase shares, proposed re-election of directors and notice of annual general meeting
April 22, 2021
Annual results announcement for the year ended December 31, 2020 change of principal place of business in hong kong change of joint company secretary, authorised representative under the listing rules and authorised representative under the hong kong companies ordinance and waiver from strict compliance with rules 3.28 and 8.17 of the listing rules
March 26, 2021